(MedPage Today) — The FDA expanded the approval of once-monthly risperidone (Uzedy) to include adjunct treatment for bipolar I disorder, drugmakers Teva Pharmaceuticals and Medincell said.
A web-based guided self-help program was just as good…
Source link : https://www.medpagetoday.com/psychiatry/generalpsychiatry/117955
Author :
Publish date : 2025-10-15 17:02:00
Copyright for syndicated content belongs to the linked Source.